LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Mei, Yingbing"
  2. AU="Han, Chenguang"
  3. AU="Ayoub, Isabelle"
  4. AU="Spencer, Sean P"
  5. AU="Papathemelis, Thomas"
  6. AU="Tzerefos, Christos"
  7. AU="Eefje Belt-van Zoen"
  8. AU="Rahmanian, Vahid"
  9. AU="Øyen, Martin Øhlund"
  10. AU="Xinyun Xuan"
  11. AU="Dana L. M. Campbell"
  12. AU="Mukta Roy"
  13. AU="Martha Funabashi"
  14. AU="Vasina, Svetlana"
  15. AU=Reber Stephan A.
  16. AU="Kenan Onel"
  17. AU="Lawrence, Marc R"
  18. AU="Zeiler, Frederick A"
  19. AU="de la Cueva, Pablo"
  20. AU="Fuh, Jerry Ying Hsi"
  21. AU="Park, Adrian J"
  22. AU="Joshi, K D"

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel: Quercetin Improves Mitochondrial Function and Inflammation in H

    Yao, Xueting / Mei, Yingbing / Mao, Wanyu

    Evidence-based complementary and alternative medicine : eCAM

    2021  Band 2021, Seite(n) 1386078

    Abstract: Functional dyspepsia (FD) is one of the most common functional gastrointestinal disorders, the therapeutic strategy of which it is limited due to its complex pathogenesis. Oxidative stress-induced damage in gastric mucosal epithelial cells is related to ... ...

    Abstract Functional dyspepsia (FD) is one of the most common functional gastrointestinal disorders, the therapeutic strategy of which it is limited due to its complex pathogenesis. Oxidative stress-induced damage in gastric mucosal epithelial cells is related to the pathogenesis and development of FD. Quercetin (Que) is one of the active ingredients of Zhishi that showed antioxidant, antiapoptotic, and anti-inflammatory effects. The aim of this study is to investigate the effect of Que on oxidative stress-induced gastric mucosal epithelial cells damage and its underlying molecular mechanism. The gastric mucosal epithelial cell line GES-1 was treated with 200
    Sprache Englisch
    Erscheinungsdatum 2021-11-27
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2171158-6
    ISSN 1741-4288 ; 1741-427X
    ISSN (online) 1741-4288
    ISSN 1741-427X
    DOI 10.1155/2021/1386078
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 5995: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Chinese patent medicine for functional dyspepsia effects: A protocol for systematic review and Bayesian network meta-analysis.

    Wu, Jingjie / Wei, Yao / Chen, Yaoxin / Long, Yu / Huang, Nierui / Mei, Yingbing

    Medicine

    2021  Band 100, Heft 47, Seite(n) e27761

    Abstract: Background: In recent years, many clinical studies have suggested that various Chinese patent medicines have the potential to treat functional dyspepsia (FD). This study aims to conduct a systematic review and Bayesian network meta-analysis to evaluate ... ...

    Abstract Background: In recent years, many clinical studies have suggested that various Chinese patent medicines have the potential to treat functional dyspepsia (FD). This study aims to conduct a systematic review and Bayesian network meta-analysis to evaluate the effectiveness of different Chinese patent medicines for FD.
    Methods: A comprehensive retrieval method will be executed in the following databases: PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBM), VIP Database, and Wanfang Database. Clinical randomized controlled trials (RCTs) of 9 Chinese patent medicines for FD are searched, and the retrieval time is from inception to October 2021. Three reviewers will screen the RCTs that meet the inclusion criteria and extract the data independently. The outcomes include total clinical efficiency, cure rate, recurrence rate, symptom score, and adverse events. Cochrane risk-of-bias tool will be carried to assess RCTs quality. The "gemtc" package and "rjags" package in R software will be used to manage data within the Bayesian framework.
    Results: The results can provide relatively objective evidence to evaluate the effectiveness of these 9 Chinese patent medicines in treating FD, which may help clinicians to develop a more effective and safer treatment plan.
    Conclusion: This study aims to provide new options for Chinese patent medicine treatment of FD in terms of its efficacy and safety.
    Mesh-Begriff(e) Drugs, Chinese Herbal/therapeutic use ; Dyspepsia/drug therapy ; Humans ; Medicine, East Asian Traditional ; Meta-Analysis as Topic ; Network Meta-Analysis ; Nonprescription Drugs/therapeutic use ; Research Design ; Systematic Reviews as Topic
    Chemische Substanzen Drugs, Chinese Herbal ; Nonprescription Drugs
    Sprache Englisch
    Erscheinungsdatum 2021-12-29
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000027761
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Ua VI Zs.171: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang